JASON BANEY: Open Payments
NPI 1063645661 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,239 in 69 payments from 16 companies in 2025. Trend: 2023 $668 · 2024 $1,128 · 2025 $1,239
Food & beverage: $1,239
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $304 |
| Lilly USA, LLC | 11 | $184 |
| Dexcom, Inc. | 4 | $175 |
| Amgen Inc. | 14 | $162 |
| PFIZER INC. | 5 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $63 |
| Lundbeck LLC | 3 | $60 |
| Ardelyx, Inc. | 2 | $42 |
| Currax Pharmaceuticals LLC | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $33 |
Products named: Ozempic, MOUNJARO, DEXCOM G7 GSS (161), OTEZLA, JARDIANCE, CAPLYTA, REXULTI, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
